Stockreport

AIM Immunotech up 105% premarket after DOD grant for cancer study [Seeking Alpha]

AIM ImmunoTech Inc.  (AIM) 
PDF AIM Immunotech up 105% premarket after DOD grant for cancer study AIM ImmunoTech (NYSEMKT: announces Shares are up 105% [Read more]